Cargando…
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial
BACKGROUND: Limited information is available on the comparative efficacy and safety of different stent platforms in patients at high bleeding risk undergoing an abbreviated dual antiplatelet therapy duration after percutaneous coronary intervention (PCI). The aim of this study was to compare the saf...
Autores principales: | Valgimigli, Marco, Wlodarczak, Adrian, Tölg, Ralph, Merkely, Béla, Kelbæk, Henning, Legutko, Jacek, Galli, Stefano, Godin, Matthieu, Toth, Gabor G., Lhermusier, Thibault, Honton, Benjamin, Dietrich, Peter Laurenz, Stammen, Francis, Ferdinande, Bert, Silvain, Johanne, Capodanno, Davide, Cayla, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516164/ https://www.ncbi.nlm.nih.gov/pubmed/37624364 http://dx.doi.org/10.1161/CIRCULATIONAHA.123.065448 |
Ejemplares similares
-
Durability of Biodegradable Polymer Nanocomposites
por: Glaskova-Kuzmina, Tatjana, et al.
Publicado: (2021) -
Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
por: Iglesias, Juan F., et al.
Publicado: (2019) -
Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis
por: Monjur, Mohammad Riashad, et al.
Publicado: (2020) -
Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020) -
Biodegradable Polymers
por: Vroman, Isabelle, et al.
Publicado: (2009)